Jens Holstein
Patrimonio netto: 1 M $ in data 31/08/2026
Patrimonio netto: 1 M $ in data 31/08/2026
Jens Holstein occupa la posizione di direttore finanziario per BioNTech SE. Il sig. Holstein è anche nel consiglio di Veracyte, Inc. Holstein ha precedentemente ricoperto la posizione di Chief Financial Officer di MorphoSys AG, Director-Finance & Labor presso Wittgensteiner Kliniken AG, Commercial Manager-Projects & Service presso Fresenius SE & Co. KGaA Managing Director presso Fresenius ProServe GmbH, Managing Director presso Fresenius Kabi Deutschland GmbH, Chief Financial Officer di Fresenius Kabi Asia Pacific Ltd. e CFO-Europe & Middle East Region presso Fresenius Kabi AG (che sono tutte filiali di Fresenius SE & Co. KGaA), General Manager per Hospitalia Care Gmbh e Commercial Manager presso Hospitalia International GmbH. Jens Holstein si è laureato all'Università di Mnster.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
VERACYTE, INC. 0,03% | 14/09/2026 | 27.471 ( 0,03% ) | 1 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VERACYTE, INC. | Direttore/Membro del Consiglio | 01/08/2020 |
| Società | Posizione | Fine |
|---|---|---|
| BIONTECH SE | Direttore Finanziario/CFO | 30/06/2025 |
| MORPHOSYS AG | Direttore Finanziario/CFO | 31/12/2020 |
| INFLARX N.V. | Direttore/Membro del Consiglio | 16/07/2020 |
Fresenius Kabi Asia Pacific Ltd.
Fresenius Kabi Asia Pacific Ltd. Medical DistributorsDistribution Services Wholesales drugs | Corporate Officer/Principal | 01/01/2010 |
Wittgensteiner Kliniken AG
Wittgensteiner Kliniken AG Hospital/Nursing ManagementHealth Services Private hospital chain | Direttore Finanziario/CFO | 01/02/2006 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 14 |
|---|---|
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
Veracyte, Inc.
Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Health Technology |
Wittgensteiner Kliniken AG
Wittgensteiner Kliniken AG Hospital/Nursing ManagementHealth Services Private hospital chain | Health Services |
Fresenius ProServe GmbH
Fresenius ProServe GmbH Hospital/Nursing ManagementHealth Services Operates and manages hospital facilities | Health Services |
University of Münster
University of Münster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InflaRx GmbH
InflaRx GmbH BiotechnologyHealth Technology Operates as a biotech company which develops new therapeutics in the field of inflammation | Health Technology |
BioNTech SE
BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
Hospitalia Care Gmbh | |
Fresenius Kabi Deutschland GmbH
Fresenius Kabi Deutschland GmbH Pharmaceuticals: GenericHealth Technology Manufactures drugs in pharmaceutical preparations for human and veterinary use | Health Technology |
Hospitalia International GmbH
Hospitalia International GmbH Medical/Nursing ServicesHealth Services Provides health care and other related services | Health Services |
Fresenius Kabi Asia Pacific Ltd.
Fresenius Kabi Asia Pacific Ltd. Medical DistributorsDistribution Services Wholesales drugs | Distribution Services |
InflaRx NV
InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale